Introduction
============

The economic costs of illness continue to play an important role in decisionmaking regarding the allocation of resources in the health sector. They represent the monetary burden on society of illness and premature death. Economic costs represent forgone alternatives and are measured in terms of direct and indirect costs. Direct costs are the value of resources that could be allocated to other uses in the absence of disease, and indirect costs are the value of lost output because of cessation or reduction of productivity caused by morbidity and mortality. Morbidity costs are wages lost by people who are unable to work because of illness and disability and an imputed value for those persons too sick to perform their usual housekeeping services. Mortality costs are the present value of future earnings lost by people who die prematurely.

Cost-of-illness estimates continue to be in demand by health planners, policymakers, and researchers. Estimates are used to set priorities, make program policy decisions, prepare and deliver Congressional testimony, and to support agency budgets. There have been more than 200 separate cost-of-illness studies in the last 20 years ([@b8-hcfr-7-1-61]). Some of these are national in scope, but most are limited to a selected population of geographic area, and all but a few are restricted to one or a few disease categories.

Several recent legislative interests and developments illustrate the importance of cost-of-illness data and the need for updating the earlier national estimates. The Health Services Research, Health Statistics, and Health Care Technology Act of 1978, Public Law 95-623, specifically discusses the methodology for estimating the costs of illness in its request that a study of the costs of environment-related health effects be conducted by the Institute of Medicine of the National Academy of Sciences. A comprehensive report was prepared, including a review of the methodologies used in developing such estimates. The report states: "There is a need for continuing estimates of the economic costs of disease that are national in scope and cover a broad spectrum of disease categories." ([@b9-hcfr-7-1-61]).

An important example of the use of these estimates is in their application to the health risks associated with smoking. Morbidity and mortality associated with smoking drain our economy heavily by reducing economic production through excess morbidity and premature death and by diverting scarce resources from other needs. The Office of Smoking and Health in the U.S. Public Health Service, the Office of Technology Assessment, and the U.S. Congress recently have focused on the need for improving the methodology for estimating the economic costs of smoking. Special interest has been expressed by the House Ways and Means Committee in the estimates of costs of smoking. The authors are currently developing more refined estimates of the economic costs of smoking by applying the proportion of health care services, illness, and deaths attributed to smoking to the total economic costs of illness presented in this article ([@b23-hcfr-7-1-61]).

The direct costs of illness in 1980 by type of care, sex, and age disaggregated for major diagnostic categories were presented in an article by [@b6-hcfr-7-1-61]. This article complements the earlier one, presenting the indirect and total economic costs of illness in 1980 by age and sex and for the 16 major diagnostic categories of the *International Classification of Diseases, Ninth Revision, Clinical Modification* (ICD-9-CM). Also presented here are the trends in the economic costs of illness by diagnosis since 1963, the first year such data were estimated ([@b19-hcfr-7-1-61]). The economic assumptions, concepts, and methodology are summarized at the end of this article.

Total economic costs in 1980
============================

Total economic costs of illness in 1980 amounted to \$455 billion based on a 4-percent discount rate of the value of productivity forgone in succeeding years as a result of premature mortality in that year ([Table 1](#t1-hcfr-7-1-61){ref-type="table"}) and \$416 billion at a 6-percent discount rate ([Table 2](#t2-hcfr-7-1-61){ref-type="table"}). Of the \$455 billion, direct costs comprised 46 percent of the total; morbidity costs, 15 percent; and mortality costs, 39 percent.

The distribution by diagnosis of total economic costs shows the greatest losses are caused by diseases of the circulatory system and injury and poisoning, accounting for \$85 billion and \$83 billion, respectively. Neoplasms (\$51 billion), diseases of the digestive system (\$42 billion), diseases of the respiratory system (\$33 billion), and mental disorders (\$31 billion) were the next most costly diseases. Together these six diseases accounted for 71 percent of the economic costs of illness.

There is considerable variation in the diagnostic distribution among the three cost components of the total (i.e., direct costs, morbidity costs, and mortality costs), reflecting the differing age, sex, medical care use, morbidity, and mortality patterns for each diagnostic group. Of the \$211 billion for annual direct expenditures, the greatest amounts are for persons with diseases of the circulatory system (\$32 billion or 15 percent) followed closely by those for persons with diseases of the digestive system (\$31 billion or 15 percent, including \$15 billion spent for dental care). Third in magnitude are expenditures for persons with mental disorders (\$20 billion), followed by those with injury and poisoning (\$19 billion).

Annual morbidity losses amount to \$68 billion. Of this total, losses are highest for persons with diseases of the circulatory system (\$11 billion), followed by those for persons with diseases of the respiratory system (\$10 billion) and mental disorders (\$9 billion). The distribution by diagnosis of mortality costs differs considerably from that of annual direct costs and morbidity losses. Of the \$176 billion losses due to deaths in 1980, injury and poisoning rank highest, accounting for \$57 billion, almost one-third of the total. Diseases of the circulatory system and neoplasms ranked second and third, respectively. Together these three major diseases account for almost three-fourths of the total mortality costs. The economic costs of illness employing a 6-percent discount rate show similar distributions by diagnosis ([Table 2](#t2-hcfr-7-1-61){ref-type="table"}).

[Figure 1](#f1-hcfr-7-1-61){ref-type="fig"} shows the distribution of each cost component (direct, morbidity, and mortality) by diagnosis. As expected, for those diagnostic groups where mortality is high, the value of these losses represent a considerably larger proportion of the total than the annual direct and morbidity cost. For example, approximately two-thirds of the total economic costs of injury and poisoning and of neoplasms represent lost lifetime earnings resulting from deaths in 1980. For diseases of the genitourinary system where mortality is low, direct expenditures comprise the largest proportion of the total--- 80 percent. Likewise, about three-fourths of the total economic costs of diseases of the nervous system and sense organs and of the digestive system are direct costs.

Morbidity losses are relatively high (about 30 percent) for diseases of the musculoskeletal system and connective tissues, mental disorders, and diseases of the respiratory system.

Costs of illness by age and sex
===============================

The total economic costs of illness for males are almost one-third higher than those for females---\$260 billion compared with \$195 billion ([Figure 2](#f2-hcfr-7-1-61){ref-type="fig"}). The distribution by sex varies considerably by type of cost. One-third of the total for males compared with two-thirds for females are direct costs. Females represented 52 percent of the population in 1980, but accounted for 59 percent of the total direct costs. Data from the National Health Interview Survey indicate that females have more days of restricted activity, more days in bed, and a higher incidence of acute conditions. They also use medical care services at a higher rate than males do, whether it be hospital or nursing home care, physicians\' or dentists\' services ([@b4-hcfr-7-1-61]).

Although morbidity rates for females are higher than those for males, when their lower labor force participation rates and lower earnings are applied, morbidity costs for males are 2½ times those for females---\$48.3 billion compared with \$19.5 billion. Mortality costs show a similar sex relationship---these costs for males are about 2.4 times those for females---\$123.7 billion compared with \$52.2 billion. The higher morbidity and mortality costs for males reflect their higher labor force participation rates, earnings, and death rates. Almost one-half of the total economic costs for males compared with one-quarter for females are mortality costs.

Patterns of losses by disease differ for males and females ([Table 3](#t3-hcfr-7-1-61){ref-type="table"}). Injury and poisoning ranks highest for males and fourth for females. Diseases of the circulatory system ranks highest for females and second for males. Neoplasms is second for females and third for males.

The economic costs of illness by diagnosis for two broad age groups---under age 65 and 65 years of age or over---are shown in [Table 4](#t4-hcfr-7-1-61){ref-type="table"}. The elderly (persons 65 years of age or over) comprised only 11.3 percent of the total population in 1980 and 18.2 percent of the total economic costs, but the differences by type of cost are significant. Chronic illnesses increase with age, and the elderly use significantly more medical care services as reflected in the high proportion (31 percent) of the direct costs they incur. Their indirect costs, however, are significantly lower---about 7 percent of the total---because of their shorter life expectancy, lower labor force participation rates and lower earnings. Thus, almost four-fifths of the total economic costs for the elderly but only two-fifths for persons under age 65 are direct costs.

The rankings by disease of the economic costs of illness vary substantially by age. For the population under age 65, the economic costs of injury and poisoning rank highest (\$78 billion), accounting for 21 percent of the total for this age group and reflecting the relatively high value of lost productivity for the large number of premature deaths at younger ages from this cause. Diseases of the circulatory system ranks second in economic costs for persons under age 65, representing 15 percent of the total. For the elderly, the economic costs of diseases of the circulatory system far outrank all other diseases--- amounting to \$29 billion, or 35 percent of the total. In second place is neoplasms, constituting 11 percent of total economic costs for the elderly.

Direct costs
============

Direct personal health care costs amounted to \$211 billion in 1980 ([Table 5](#t5-hcfr-7-1-61){ref-type="table"}). Ranking the direct costs by major diagnostic categories reveals that diseases of the circulatory system is highest followed by diseases of the digestive system, mental disorders, and injury and poisoning. Costs for diseases of the digestive system include all expenditures for dental services, which account for almost one-half the total direct costs of this category.

Of the total direct personal health care costs, \$124 billion (or 59 percent) are attributed to females who comprised 51 percent of the total population in 1980. The relatively higher direct costs for females reflect the larger number of females, especially older ones requiring medical care services, and their greater use of medical services throughout the age range.

Medical care costs increase significantly with age; the elderly consume 31 percent of the direct costs. The diagnostic rankings for the two age groups vary substantially. For the age group under 65 years, diseases of the digestive system and injury and poisoning rank first and second, respectively. For the elderly, diseases of the circulatory system far outranked all other diseases, comprising 31 percent of the total direct costs. Mental disorders, diseases of the digestive system, and neoplasms follow, each representing about 9 percent of the total.

Morbidity costs
===============

Calculations of morbidity costs involve applying average earnings to work-loss years for the currently employed, attaching a dollar value to housekeeping services for those unable to perform these services because of illness, and applying labor force participation rates and earnings to persons who are too sick to be employed. Work-loss years are derived from work-loss days and days of housekeeping lost from bed-disability days among females usually keeping house---estimated by the National Health Interview Survey (NHIS). Persons too sick to be employed include noninstitutionalized persons unable to work and residents of institutions. The number unable to work is published by the Bureau of Labor Statistics and includes persons unable to work because of long-term physical or mental illness. This is a conservative estimate, excluding those persons who expect to return to work within 6 months. The total number unable to work is allocated to diagnoses according to the distribution of persons unable to work and the main cause of limitation of activity in the NHIS. The number of persons in institutions is reported by the U.S. Bureau of the Census and is allocated to diagnoses according to the type of institution. For example, persons in mental hospitals, residential treatment centers, and homes for the mentally handicapped are classified under mental disorders; those in homes for the aged and in chronic disease hospitals are classified according to the distribution of primary diagnoses among nursing home residents in the National Nursing Home Survey. [Table 6](#t6-hcfr-7-1-61){ref-type="table"} shows the economic variables used in estimating morbidity costs.

In 1980, employed males and females, females usually keeping house, those unable to work, and institutionalized persons lost the equivalent of 6.2 million person years at a value of \$67.8 billion ([Table 7](#t7-hcfr-7-1-61){ref-type="table"}). About 46 percent of the person years lost were for males whose morbidity costs represented 71 percent of the total because of their higher labor force participation and earnings. Person years lost for those under age 65 comprised 70 percent of the total, but their productivity losses represented 95 percent of the total. Diseases of the circulatory system ranked highest in person years lost for both men and women and for those persons 65 years of age or over. For males, productivity losses from diseases of the circulatory system ranked highest; for females productivity losses from diseases of the respiratory system ranked highest. For both age groups, morbidity costs were highest for those with diseases of the circulatory system.

Lifetime earnings
=================

If individuals had not died prematurely, they would have continued to be productive for a number of years. It is the present value of future productivity losses that constitute an important component of the indirect costs of a disease. For mortality, the estimated cost or value to society of all deaths is the product of the number of deaths and the expected value of an individual\'s future earnings with sex and age taken into account. This method of derivation takes into consideration life expectancy for different age and sex groups, changing patterns of earnings at successive ages, varying labor force participation rates, imputed value for housekeeping services, and the appropiate discount rate to convert a stream of costs or benefits into its present worth. This approach is commonly known as the human capital approach, and it will be discussed further in the section, Economic assumptions, concepts, and methodology.

The present value of future earnings discounted at 4 and 6 percent is shown in [Table 8](#t8-hcfr-7-1-61){ref-type="table"} and [Figure 3](#f3-hcfr-7-1-61){ref-type="fig"}. For a male infant under age 1, the expected lifetime earnings discounted at 4 percent are \$415,998. The present value of male lifetime earnings reaches a peak of \$604,379 for the age group 20-24, and decreases steadily to \$914 for those 85 years of age or over.

The level of expected lifetime earnings for females is somewhat lower than that for males up to age 69. An infant female can be expected to earn \$330,065 in her lifetime, or 79 percent of that for males. The highest expected lifetime earnings (\$448,982) are for females in the age group 20-24. Peak male earnings are about 35 percent higher than those for females.

Beginning with the age group 65-69, female earnings are higher. Discounted at 4 percent, the present value of lifetime earnings for females in this age group is \$37,104 compared with \$25,887 for males. At ages 85 and over, female lifetime earnings are valued at \$1,197 compared with only \$914 for males. The higher expected earnings for females in the older age groups are the result of the relatively small number of males in the labor force and the larger number of females keeping house.

Application of a 6-percent discount rate results in a similar pattern, but with somewhat lower figures. The present value of expected earnings for the male infant is \$200,992, or less than one-half of the earnings for this age group discounted at the lower rate of 4 percent. The peak earnings for males are in the age group 25-29---amounting to \$446,490, or three-fourths the amount obtained with a 4-percent discount rate. Female earnings discounted at 6 percent follow the same pattern as those calculated at the lower rate.

Mortality costs
===============

Applying the expected lifetime earnings by age and sex to the almost 2 million deaths in 1980 results in a loss of approximately 35 million person years, representing a loss of \$176 billion to the economy at a 4-percent discount rate and \$137 billion at a 6-percent discount rate ([Table 9](#t9-hcfr-7-1-61){ref-type="table"}). For the more than 1 million males who died in 1980, an estimated total of 19.4 million person years were lost, valued at \$124 billion, at a 4-percent discount rate and \$96 billion at a 6-percent discount rate. About 915,000 females died in 1980--- representing a loss of 15.8 million person years, or 45 percent of all the years lost. Because of the higher earnings of males, losses for females are significantly lower, amounting to \$52 billion at a 4-percent discount rate and \$41 billion at a 6-percent discount rate. Thus, males account for 54 percent of the deaths, 55 percent of the person years lost, and 70 percent of the productivity losses. Diseases of the circulatory system ranked highest for both male and female deaths and person years lost. The pattern is different for productivity losses, however; injury and poisoning ranked highest for males and neoplasms for females. Premature deaths from these causes are very costly to the Nation.

The number of deaths, person years lost, and discounted earnings vary by age for each category of loss ([Table 10](#t10-hcfr-7-1-61){ref-type="table"}). The highest number and proportion of deaths are among the aged, representing more than two-thirds of the total. The total person years lost, a function of both age and number of deaths, shows a different picture. Persons 65 years of age or over who died would have had relatively few remaining years of life; and their deaths, therefore, represented only 38 percent of the person years lost. In terms of lost earnings, at a 4-percent discount rate, this age group accounts for only 8 percent of the total. The much higher earnings losses for those who died at ages under 65 are the result of their considerably higher expected lifetime earnings.

[Table 10](#t10-hcfr-7-1-61){ref-type="table"} also presents the number of deaths, person years, and productivity losses for the major diagnostic categories by the two broad age groups, showing the effect of age on each of these measures of loss. Diseases of the circulatory system primarily affect the aged who have relatively low future earnings; these diseases represent one-half of all deaths but one-third of the years lost and less than one-quarter of the productivity losses. Considerable variation also is found among the diagnoses. As expected, for those diagnoses where the younger age groups account for a substantial number of deaths, these same age groups represent a considerably larger proportion of the person years lost and of the expected lifetime earnings. For example, 80 percent of the deaths in 1980 due to injury and poisoning are of persons under 65 years of age, accounting for 95 percent of person years lost and 99 percent of the productivity losses for that cause.

For those diseases where the majority of deaths are of persons 65 years of age or over, the pattern is different; this age group accounts for a smaller proportion of the total years lost than of deaths and an even smaller proportion of the total earnings lost. An example is deaths from diseases of the circulatory system of which 80 percent were of persons 65 years of age or over representing 61 percent of the years lost but only 18 percent of the lost earnings at the 4-percent discount rate. It is clear that for each diagnostic group the age distribution of deaths directly affects the distribution of the total earnings lost.

Economic costs of illness trends
================================

Previous comparable data on the economic costs of illness have been estimated for the following years: 1963 ([@b19-hcfr-7-1-61]), 1972 ([@b2-hcfr-7-1-61]), 1975 ([@b17-hcfr-7-1-61]), and 1977 ([@b5-hcfr-7-1-61]; [@b20-hcfr-7-1-61]; and [@b21-hcfr-7-1-61]). Data for 1963, 1972, and 1980 are shown in [Tables 11](#t11-hcfr-7-1-61){ref-type="table"} and [12](#t12-hcfr-7-1-61){ref-type="table"}, enabling examination of the trends in the economic costs of illness over more or less comparable intervals---9 years between 1963 and 1972 and 8 years between 1972 and 1980.

For comparative purposes, the 1980 economic costs of illness based on the present value of lifetime earnings discounted at 6 percent are also shown in the tables. These costs represent estimates of lifetime earnings at the 6-percent discount rate adjusted for a 2-percent annual change in productivity. They are equivalent to the estimates in 1963 and 1972 of the economic costs of illness incorporating lifetime earnings at the 4-percent discount rate. The 4-percent rate in 1963 and 1972 is a net discount rate obtained by adjusting a 6-percent discount rate by a 2-percent rise in productivity (1.06/1.02 = 1.04).

The trends in the distribution of economic costs of illness by diagnosis are shown in [Table 11](#t11-hcfr-7-1-61){ref-type="table"}. The costs of illness caused by diseases of the circulatory system have steadily declined as a proportion of the total--- from 22 percent in 1963 to 19 percent in 1980, reflecting the decline in death rates for this major cause during this period. The economic costs of injury and poisoning, on the other hand, have grown in importance---rising from 12.6 percent of the total in 1963 to 14.1 percent in 1972 and to 16.3 percent in 1980, reflecting the rise in deaths from these causes, especially at the younger ages. The economic costs of neoplasms have also risen, from 9.2 percent in 1972 to 11.0 percent in 1980 because of the continued rise in cancer mortality. In 1963, deaths from neoplasms comprised 16 percent of total deaths; in 1980 it was 23 percent.

[Table 12](#t12-hcfr-7-1-61){ref-type="table"} reveals the tremendous rise in the economic costs of illness over the 17-year period, 1963-80. The total rose almost 350 percent during this period, representing an average annual growth rate of 9.2 percent. During this period of very high inflation in the medical care market, direct costs increased 837 percent, an average annual growth rate of 14.1 percent. Between 1965 and 1980, price increases accounted for 58 percent of the growth in health care expenditures. Changes in use and/or kinds of services and supplies were responsible for 33 percent of the growth in expenditures, and 9 percent of the increase resulted from changes in population size ([@b14-hcfr-7-1-61]). Indirect costs, on the other hand, rose at a much slower rate---189 percent in the 17-year period, an average annual rate of 6.4 percent. Indirect costs reflect in part the slower rate of growth in wages relative to medical care costs and a relatively small increase in the number of deaths---10 percent.

The effects of direct and indirect costs on the total costs of illness have been changing over time, with a dramatic increase in direct costs relative to indirect costs in recent years. In her landmark study of the cost of illness from 1900 to 2000, [@b13-hcfr-7-1-61] estimated that indirect costs were 8 times that of direct costs in 1900. By 1930, the relative magnitude of indirect costs dropped slightly so that they represented less than 7 times the direct costs. In 1963, indirect costs were about 3 times that of direct costs; by 1972, they were only 1½ times the direct costs. By 1980, direct costs had increased so rapidly that the long-term relationship between the two types of costs was reversed. Direct costs were slightly higher than indirect costs, indicating the varying impacts of such factors as inflation in medical care costs and wage increases that determine the cost of illness.

Direct costs also play a significant role in the trends in the distribution of the costs of specific diseases. Several conditions that have high medical costs and low death rates have gained in relative importance since 1963. For example, diseases of the digestive system rose from 8.4 to 9.9 percent of their total economic costs from 1963 to 1980. Direct costs, including expenditures for dental services, comprised 53 percent of the total economic costs for this major diagnostic category in 1963; by 1980, the proportion rose to 75 percent. Another example is diseases of the skin and subcutaneous tissue. Direct costs for this category represented 55 percent of the total economic costs in 1963; by 1980, this proportion rose to 90 percent. In both years, deaths from these causes comprised less than 2 percent of the total.

Economic assumptions, concepts, and methodology
===============================================

The detailed methodology for estimating the economic costs of illness has been documented elsewhere ([@b19-hcfr-7-1-61]; [@b2-hcfr-7-1-61]; [@b6-hcfr-7-1-61]). The 1980 estimates in this article replicate the methodology used in developing the 1976 estimates, where the major change from the 1963 estimates was in the valuation of housekeeping services discussed later. The economic assumptions, principles, and methodological problems in estimating the direct costs and the value of losses of output resulting from illness and death are summarized later.

Human capital and willingness-to-pay approaches
-----------------------------------------------

There are two principal methodologies for estimating the cost of illness: the human capital method and the willingness-to-pay method. The former method, used in this study, is called the human capital or output accounting approach because an employed person is seen as producing a stream of output over the years that is valued at the individual\'s earnings. The main criticism of this methodology is that it excludes intangibles, only counts earnings, and undervalues some groups relative to others because earnings may not accurately reflect one\'s ability to produce. Thus males are more highly valued than females, white persons more than black persons, and middle-aged people more than the young and elderly, with part of the difference a result of racial and sexual discrimination.

The willingness-to-pay method values human life according to the amount people are willing to spend to obtain reductions in the probability of death ([@b24-hcfr-7-1-61] and [@b1-hcfr-7-1-61]). This method could be helpful in indicating how individuals value health and life, in deriving social preferences regarding public policy, and in assessing the burden of pain and suffering, which have an intangible quality that is not amenable to evaluation in terms of the monetary value of resources used or foregone ([@b22-hcfr-7-1-61]). Objections to this method are that the value of individual lives depends on the income distribution, with the rich able to pay more than the poor, and that it is exceedingly difficult for persons to place a value on small reductions in the probability of death. The strengths and weaknesses of these two methodologies are discussed fully in two recent articles on the state of the art of cost-of-illness estimation by [@b7-hcfr-7-1-61] and by [@b5-hcfr-7-1-61].

The human capital and willingness-to-pay methods are not simply alternatives. Together or separately, each can contribute to greater understanding of the burden of disease and other hazards. Unfortunately, the precise nature of the relationship between values calculated by the human capital approach and those implied by the willingness-to-pay method has not been determined. Although it is not known to what extent the two values would differ if willingness to pay for small reductions in mortality risk could be calculated, lifetime earnings as estimated by the human capital method may at least be a lower bound to a person\'s willingness to pay for a decreased risk of death ([@b11-hcfr-7-1-61]; [@b9-hcfr-7-1-61]; and [@b10-hcfr-7-1-61]).

The human capital approach is still most often used in cost-benefit and cost-effectiveness analyses that seek to evaluate alternative demands for scarce health care resources and promote economic rationality in health services policy, planning, and management. Many studies use the human capital approach for it provides valuable information based on reliable statistics, so long as one realizes its limitations ([@b8-hcfr-7-1-61]).

Prevalence and incidence estimates
----------------------------------

Two approaches can be used in estimating the costs of illness by the human capital method. Prevalence-based costs provide an estimate of the direct and indirect economic burden incurred in a period of time (the base period) as a result of the prevalence of disease during this same base period, most often a year. Included are the costs of the base year manifestations or sequelae of disease that may have had its onset in the base year or at any time prior to the base year. Prevalence costs measure the value of resources used or lost during a specified period of time, regardless of the time of disease onset. The economic costs of illness estimates in this article employ the prevalence-based approach.

Incidence costs represent the lifetime costs resulting from the disease or illness. In the aggregate, incidence costs in a given base year refer to the total lifetime costs of all cases with onset of disease in the base year. Incidence costs are difficult to estimate because they require knowledge of the likely course of a disease and its duration, including survival rates since onset; medical care that will be used and its cost during the duration of the disease; and the impact of the disease on employment, housekeeping, and earnings ([@b5-hcfr-7-1-61] and [@b25-hcfr-7-1-61]).

Relatively few incidence-based studies exist, but the current state of the art is illustrated by [@b3-hcfr-7-1-61], who estimate the costs of cancer, coronary heart disease, stroke, and motor vehicle injuries; [@b18-hcfr-7-1-61], who examine the costs of breast cancer, diabetes melitus, rheumatoid arthritis, stroke, and acute lymphocytic leukemia; and [@b16-hcfr-7-1-61], who estimate the costs of smoking and benefits of quitting.

Nonhealth sector costs
----------------------

The direct costs of illness presented here do not include certain costs borne by patients and other individuals. These nonhealth sector costs include costs of transportation to health providers, certain household expenditures, costs of relocating, and certain property losses. Illness can force a family to incur expenses in caring and providing for the sick member of the family, including extra expenditures for household help; special diets; special clothing; items such as exercycles, vaporizers, humidfiers, and dehumidfiers for rehabilitation and comfort; alterations of property, such as elevators for invalids and other special housing facilities; vocational, social, and family counseling services. Property losses include destruction of property resulting, for example, from alcoholism and alcohol abuse and criminal activity brought on by drug addiction. Another example is the depressed value of property because of risks to health because of environmental conditions, such as air and water pollution, solid waste areas, and nuclear power plants. Other costs originating in disease or illness are expenditures for retraining or reeducation and care provided by family and friends ([@b5-hcfr-7-1-61] and [@b25-hcfr-7-1-61]). All of these nonhealth sector costs are omitted from the cost-of-illness estimates presented here. Consideration should be given, however, to estimating these costs when cost-benefit analyses are conducted.

Psychosocial costs
------------------

Illness and disease are responsible for a wide variety of deteriorations in the quality of life that are frequently referred to as psychosocial costs. Victims of illness and disease, families of victims, friends and coworkers of victims, and those who render care may all be affected. Victims may suffer loss of a body part or speech, disfigurement, disability, the pain and grief of impending death. They and those around them may be forced into economic dependence and social isolation, unwanted job changes, loss of opportunities for promotion and education, relocation of living quarters, and other undesired changes in life plans ([@b7-hcfr-7-1-61]). The combination of financial strain and psychosocial problems can be especially devastating; but because these costs are difficult to estimate, they are omitted from the cost estimates in this article.

Multiple diseases
-----------------

The presence of multiple disease presents problems for estimating both the direct and indirect costs of illness ([@b25-hcfr-7-1-61]). The primary diagnosis is used for estimating hospital and nursing home direct costs of the disease. Basic data available from the National Health Interview Survey for measuring losses in output for currently employed persons and for housewives include multiple listing of conditions, with no indication as to the primary cause of work loss. In the 1980 estimates as in previous years, reported work-loss days associated with acute and chronic conditions are uniformly adjusted downward for each diagnosis to eliminate duplication caused by disability for which more than one disease or condition was mentioned. The same procedure is followed for females keeping house who reported that more than one condition prevented them from carrying on the major activity of keeping house. The effect is to reduce the loss in output associated with each cause of disability; to have added the multiple conditions would have resulted in overstating the total losses in output for these groups of disabled persons. It is recognized that application of a uniform factor assumes that all associated conditions are evenly distributed, which is obviously not the case. For example, heart disease conditions are much more likely than cancer to be secondary causes of disability.

Employment
----------

The estimates of lifetime earnings takes into account varying labor force participation rates. The assumption is that people will be working and productive during their expected lifetime in accordance with the current pattern of work experience for their sex and age group. For this calculation, the percent of the population with earnings in 1980 published by the U.S. Bureau of Census were used ([Table 6](#t6-hcfr-7-1-61){ref-type="table"}).

There is considerable evidence that a radical change has taken place among American females in recent years in many dimensions of labor supply ([@b15-hcfr-7-1-61]). More than one-half of the females of working age now are employed compared with about one-third in the early 1950\'s. Each successive cohort of females has higher levels and more continuous patterns of labor force attachment than the preceding one. For each age group, however, a significantly higher proportion of males than of females were employed in 1980, with the highest proportion of males at ages 30-34 (96.3 percent) and the highest proportion of females at ages 20-24 (80.9 percent). The largest differential, however, is at the older age groups, where relatively few females are employed.

Earnings
--------

The appropriate measure of output loss for individuals is earnings, and the proper measure of expected earnings is the arithmetic average or mean. In this article, output losses are based on annual mean earnings in 1980 by age and sex, adjusted for wage supplements such as employer contributions for social insurance, private pensions, and welfare funds.

Cross-sectional profiles of mean earnings by age and sex are used to estimate lifetime earnings. In applying these data, it is assumed that the future pattern of earnings for an average individual within a sex group will follow the pattern reported by the Census Bureau during the base year of 1980. This model recognizes that individuals, on the average, may expect their earnings to rise with age and experience in accordance with the cross-sectional data for 1980.

The differentials in earnings continue to be large between the sexes. As indicated in [Table 6](#t6-hcfr-7-1-61){ref-type="table"}, male earnings are higher for each age group, ranging from 26 percent higher for the youngest working ages to 146 percent higher for ages 45-49. Use of higher labor force participation rates and higher earnings for males in measuring output losses has a significant impact on the economic costs of illness for males and females.

Household work
--------------

Marketplace earnings underestimate the loss resulting from females\' illnesses, and the value of household work must be added to earnings. Based on a time-motion study of housekeepers, the relevant market wages for various services performed were multiplied by the time required for doing that service to obtain an estimate of the cost of replacing the houskeeper\'s duties with person hours from the labor force ([@b26-hcfr-7-1-61]). The value of housekeeping services for females not in the labor force and for employed males and females are estimated and shown in [Table 6](#t6-hcfr-7-1-61){ref-type="table"}. Imputed household values plus marketplace earnings result in total earnings, which were used to compute the present value of lifetime earnings.

The discount rate
-----------------

The calculation of the present value of expected lifetime earnings raises questions about the importance of discounting and choosing the appropriate discount rate. From the economist\'s viewpoint, the arithmetic sum of lifetime earnings overstates the present value of an individual. Determining the present value of the future earnings stream is the correct way to measure economic value over a period of time; discounting converts a stream of earnings into its present value.

Economists agree that comparison of streams of earnings over varying timespans should employ the process of discounting. It is now generally agreed that the benefits of public projects for which costs-of-illness estimates are used should be discounted at the social rate of time preference. This rate correctly states society\'s preference for present versus future consumption. Unfortunately, the social rate of time preferences is unobservable and the actual value is uncertain. [@b7-hcfr-7-1-61] discuss the discount rate in more detail and recommend that investigators employ at least two and preferably three discount rates ranging from 2.5 percent to 10 percent.

The higher the discount rate, the lower the present value of a given stream. With a high discount rate, earnings far into the future yield a relatively small present value. Conversely, lowering the discount rate increases the present value of future earnings. It is important for policymakers to know whether cost estimates are appreciably affected by alternative discount rates.

The discount rate can be adjusted for expected changes in productivity. An annual increase in productivity of 2 percent, for example, can be incorporated into the discounting calculations to obtain a net effective discount rate. Thus a 6-percent discount rate adjusted for an annual 2-percent rise in productivity will yield an effective discount rate of approximately 4 percent (1.06/1.02 = 1.039). An 8-percent discount rate similarly adjusted results in a rate of 6-percent (1.08/1.02-1.059). The present values of lifetime earnings by age and sex for discount rates of 4 and 6 percent, adjusted for an annual increase in productivity of 2 percent a year, are given in [Table 8](#t8-hcfr-7-1-61){ref-type="table"}.

Consumption
-----------

In the past it has been questioned whether the cost of morbidity and mortality caused by illness is the output of individuals or the output minus their consumption ([@b27-hcfr-7-1-61]). The concern of this study is with the cost of illness to society. Individuals, not just the output they contribute in excess of consumption, are valued by society. Economists today generally agree that consumption should not be deducted ([@b12-hcfr-7-1-61]).

Summary and conclusions
=======================

This article presents a replication and update of the economic costs of illness---the economic burden resulting from illness, disability, and death in 1980. It employs the human capital approach in which morbidity and mortality are translated to direct and indirect costs to society as a result of these losses. The greatest losses are for diseases of the circulatory system and for injury and poisoning, with variations in the diagnostic distributions among the three types of costs and by age and sex. Some shifts in the ranking of the major diseases were observed over the 17-year period, 1963-80, for which cost-of-illness data are available.

It is important to remember that an inherent limitation to the approach to valuing life is the difference in economic rewards accruing to males and females. The differentials in earnings continue to be large between the sexes. Males also have higher labor force participation rates. Use of these higher labor force participation rates and higher earnings for males in measuring output losses resulting from morbidity and premature mortality has a significant impact on the economic costs for males and females.

Lower economic costs are potential benefits of reduced morbidity and mortality. Knowledge of the costs of specific diseases is an aid to more rational decisionmaking with respect to allocating scarce resources among competing ends. The methodology employed is a means for estimating the burden of disease on society.
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###### Estimated amounts and percent distribution of total economic costs, by diagnosis and type of cost: 1980

  Diagnosis                                                            Total       Direct costs   Indirect costs   Total       Direct costs   Indirect costs           
  -------------------------------------------------------------------- ----------- -------------- ---------------- ----------- -------------- ---------------- ------- -------
  Total                                                                \$454,882   \$211,143      \$67,827         \$175,912   100.0          100.0            100.0   100.0
  Infectious and parasitic diseases                                    10,266      4,300          4,107            1,859       2.3            2.0              6.1     1.1
  Neoplasms                                                            50,538      13,049         5,778            31,711      11.1           6.2              8.5     18.0
  Endocrine, nutritional, metabolic diseases, and immunity disorders   12,840      7,329          2,237            3,274       2.8            3.5              3.3     1.9
  Diseases of blood and blood-forming organs                           2,050       1,155          281              614         0.5            0.5              0.4     0.3
  Mental disorders                                                     30,685      19,824         8,917            1,944       6.7            9.4              13.1    1.1
  Diseases of the nervous system and sense organs                      22,991      17,132         2,616            3,243       5.1            8.1              3.9     1.8
  Diseases of the circulatory system                                   85,008      32,488         11,448           41,072      18.7           15.4             16.9    23.3
  Diseases of the respiratory system                                   33,120      16,661         10,146           6,313       7.3            7.9              15.0    3.6
  Diseases of the digestive system                                     42,437      30,974         3,441            8,022       9.3            14.7             5.1     4.6
  Diseases of the genitourinary system                                 15,414      12,313         1,762            1,339       3.4            5.8              2.6     0.8
  Diseases of the skin and subcutaneous tissue                         6,600       5,940          539              121         1.5            2.8              0.8     0.0
  Diseases of the musculoskeletal system and connective tissue         20,588      13,124         6,938            526         4.5            6.2              10.2    0.3
  Congenital anomalies                                                 6,319       1,345          ---              4,974       1.4            0.6              ---     2.8
  Symptoms, signs, and ill-defined conditions                          10,710      3,815          1,847            5,048       4.3            1.8              2.7     2.9
  Injury and poisoning                                                 82,959      18,684         7,234            57,041      18.2           8.8              10.7    32.4
  Other conditions[^1^](#tfn1-hcfr-7-1-61){ref-type="table-fn"}        18,093      8,746          536              8,811       2.0            4.1110           0.8     5.0
  Unallocated expenditures                                             4,265       4,265          ---              ---         0.9            2.0              ---     ---

Includes complications of pregnancy, childbirth, and puerperium and certain conditions originating during the perinatal period.

Present value of lifetime earnings discounted at 4 percent.

NOTE: Numbers and percents may not add due to rounding.

###### Estimated amounts and percent distribution of total economic costs, by diagnosis and type of cost: 1980

  Diagnosis                                                            Total       Direct costs   Indirect costs   Total       Direct costs   Indirect costs           
  -------------------------------------------------------------------- ----------- -------------- ---------------- ----------- -------------- ---------------- ------- -------
  Total                                                                \$415,918   \$211,143      \$67,827         \$136,948   100.0          100.0            100.0   100.0
  Infectious and parasitic diseases                                    9,793       4,300          4,107            1,386       2.4            2.0              6.1     1.0
  Neoplasms                                                            45,821      13,049         5,778            26,994      11.0           6.2              8.5     19.7
  Endocrine, nutritional, metabolic diseases, and immunity disorders   12,211      7,329          2,237            2,645       2.9            3.5              3.3     1.9
  Diseases of blood and blood-forming organs                           1,900       1,155          281              464         0.5            0.5              0.4     0.3
  Mental disorders                                                     30,312      19,824         8,917            1,571       7.3            9.4              1.3     1.1
  Diseases of the nervous system and sense organs                      22,087      17,132         2,616            2,339       5.3            8.1              3.9     1.7
  Diseases of the circulatory system                                   79,658      32,488         11,448           35,722      19.2           15.4             16.9    26.1
  Diseases of the respiratory system                                   31,872      16,661         10,146           5,065       7.7            7.9              15.0    3.7
  Diseases of the digestive system                                     41,109      30,974         3,441            6,694       9.9            14.7             5.1     4.9
  Diseases of the genitourinary system                                 15,171      12,313         1,762            1,096       3.6            5.8              2.6     0.8
  Diseases of the skin and subcutaneous tissue                         6,578       5,940          539              99          1.6            2.8              0.8     0.0
  Diseases of the musculoskeletal system and connective tissue         20,489      13,124         6,938            427         4.9            6.2              10.2    0.3
  Congenital anomalies                                                 4,057       1,345          ---              2,712       1.0            0.6              ---     2.0
  Symptoms, signs, and ill-defined conditions                          8,959       3,815          1,847            3,297       2.2            1.8              2.7     2.4
  Injury and poisoning                                                 67,995      18,684         7,234            42,077      16.3           8.8              10.7    30.7
  Other conditions[^1^](#tfn4-hcfr-7-1-61){ref-type="table-fn"}        13,642      8,746          536              4,360       3.3            4.1              0.8     3.2
  Unallocated expenditures                                             4,265       4,265          ---              ---         1.0            2.0              ---     ---

1ncludes complications of pregnancy, childbirth, and puerperium and certain conditions originating during the perinatal period.

Present value of lifetime earnings discounted at 6 percent.

NOTE: Numbers and percents may not add due to rounding.

###### Estimated amounts of total economic costs, by diagnosis, sex, and type of cost: 1980

  Diagnosis                                                            Male        Female                                                               
  -------------------------------------------------------------------- ----------- ---------- ---------- ----------- ----------- ----------- ---------- ----------
  Total                                                                \$259,601   \$87,618   \$48,305   \$123,678   \$195,281   \$123,525   \$19,522   \$52,234
  Infectious and parasitic diseases                                    5,818       1,820      2,845      1,153       4,448       2,840       1,262      706
  Neoplasms                                                            28,139      5,647      4,138      18,354      22,399      7,402       1,640      13,357
  Endocrine, nutritional, metabolic diseases, and immunity disorders   5,835       2,354      1,673      1,808       7,005       4,975       564        1,466
  Diseases of blood and blood-forming organs                           952         427        171        354         1,098       728         110        260
  Mental disorders                                                     17,895      9,330      7,024      1,541       12,790      10,494      1,893      403
  Diseases of the nervous system and sense organs                      11,566      7,558      1,905      2,103       11,425      9,574       711        1,140
  Diseases of the circulatory system                                   51,905      13,932     9,185      28,788      33,103      18,556      2,263      12,284
  Diseases of the respiratory system                                   18,629      8,096      6,403      4,130       14,491      8,565       3,743      2,183
  Diseases of the digestive system                                     21,238      13,428     2,237      5,573       21,199      17,546      1,204      2,449
  Diseases of the genitourinary system                                 5,062       3,509      779        774         10,352      8,804       983        565
  Diseases of the skin and subcutaneous tissue                         3,052       2,573      419        60          3,548       3,367       120        61
  Diseases of the musculoskeletal system and connective tissue         10,341      5,053      5,114      174         10,247      8,071       1,824      352
  Congenital anomalies                                                 3,629       626        ---        3,003       2,690       719         ---        1,971
  Symptoms, signs, and ill-defined conditions                          6,210       1,654      1,125      3,341       4,500       2,161       722        1,617
  Injury and poisoning                                                 62,071      9,783      5,287      47,001      20,888      8,901       1,947      10,040
  Other conditions[^1^](#tfn7-hcfr-7-1-61){ref-type="table-fn"}        5,762       331        ---        5,431       12,331      8,415       536        3,380
  Unallocated expenditures                                             1,496       1,496      ---        ---         2,769       2,769       ---        ---

Includes complications of pregnancy, childbirth, and puerperium and certain conditions originating during the perinatal period.

Present value of lifetime earnings discounted at 4 percent.

NOTE: Numbers and percents may not add due to rounding.

###### Estimated amounts of total economic costs, by diagnosis, age, and type of cost: 1980

  Diagnosis                                                            Under 65 years   65 years or over                                                          
  -------------------------------------------------------------------- ---------------- ------------------ ---------- ----------- ---------- ---------- --------- ----------
  Total                                                                \$372,172        \$146,191          \$64,168   \$161,813   \$82,708   \$64,950   \$3,659   \$14,099
  Infectious and parasitic diseases                                    9,438            3,731              3,963      1,744       828        569        144       115
  Neoplasms                                                            41,340           7,727              5,552      28,061      9,196      5,320      226       3,650
  Endocrine, nutritional, metabolic diseases, and immunity disorders   9,345            4,362              2,096      2,887       3,496      2,968      141       387
  Diseases of blood and blood-forming organs                           1,541            706                265        570         509        449        16        44
  Mental disorders                                                     24,638           14,136             8,622      1,880       6,048      5,689      295       64
  Diseases of the nervous system and sense organs                      18,226           12,661             2,467      3,098       4,765      4,471      149       145
  Diseases of the circulatory system                                   56,282           12,384             10,258     33,640      28,727     20,105     1,190     7,432
  Diseases of the respiratory system                                   27,656           12,520             9,793      5,343       5,464      4,141      353       970
  Diseases of the digestive system                                     36,095           25,303             3,270      7,522       6,342      5,671      171       500
  Diseases of the genitourinary system                                 12,673           9,873              1,666      1,134       2,742      2,441      96        205
  Diseases of the skin and subcutaneous tissue                         5,399            4,796              502        101         1,201      1,144      37        20
  Diseases of the musculoskeletal system and connective tissue         16,276           9,300              6,496      480         4,312      3,824      442       46
  Congenital anomalies                                                 6,218            1,257              ---        4,961       101        88         ---       13
  Symptoms, signs, and ill-defined conditions                          9,562            3,044              1,612      4,906       1,148      771        235       142
  Injury and poisoning                                                 78,223           14,478             7,070      56,675      4,736      4,206      164       366
  Other conditions[^1^](#tfn10-hcfr-7-1-61){ref-type="table-fn"}       18,034           8,687              536        8,811       59         59         ---       ---
  Unallocated expenditures                                             1,229            1,229              ---        ---         3,036      3,036      ---       ---

1ncludes complications of pregnancy, childbirth, and puerperium and certain conditions originating during the perinatal period.

Present value of lifetime earnings discounted at 4 percent.

NOTE: Numbers and percents may not add due to rounding.

###### Estimated amounts of direct costs, by sex, age, and diagnosis: 1980

  Diagnosis                                                            Total                                                     Sex        Age                     
  -------------------------------------------------------------------- --------------------------------------------------------- ---------- ----------- ----------- ----------
  Total                                                                [^2^](#tfn14-hcfr-7-1-61){ref-type="table-fn"}\$211,143   \$87,618   \$123,525   \$146,191   \$64,950
  Infectious and parasitic diseases                                    4,300                                                     1,820      2,480       3,731       569
  Neoplasms                                                            13,049                                                    5,647      7,402       7,727       5,322
  Endocrine, nutritional, metabolic diseases, and immunity disorders   7,329                                                     2,354      4,975       4,362       2,968
  Diseases of blood and blood-forming organs                           1,155                                                     427        728         706         449
  Mental disorders                                                     19,824                                                    9,330      10,494      14,136      5,689
  Diseases of the nervous system and sense organs                      17,132                                                    7,558      9,574       12,661      4,471
  Diseases of the circulatory system                                   32,488                                                    13,932     18,556      12,384      20,105
  Diseases of the respiratory system                                   16,661                                                    8,096      8,565       12,520      4,141
  Diseases of the digestive system                                     30,974                                                    13,428     17,546      25,303      5,671
  Diseases of the genitourinary system                                 12,313                                                    3,509      8,804       9,873       2,441
  Diseases of the skin and subcutaneous tissue                         5,940                                                     2,573      3,367       4,796       1,144
  Diseases of the musculoskeletal system and connective tissue         13,124                                                    5,053      8,071       9,300       3,8245
  Congenital anomalies                                                 1,345                                                     626        719         1,259       88
  Symptoms, signs, and ill-defined conditions                          3,815                                                     1,654      2,161       3,044       771
  Injury and poisoning                                                 18,684                                                    9,783      8,901       14,478      4,206
  Other conditions[^1^](#tfn13-hcfr-7-1-61){ref-type="table-fn"}       8,746                                                     331        8,415       8,687       59
  Unallocated expenditures                                             4,265                                                     1,496      2,769       1,229       3,036

Includes complications of pregnancy, childbirth, and puerperium and certain conditions originating during the perinatal period.

Excludes \$8.3 billion of personal health care expenditures that could not be allocated by age and sex.

NOTE: Numbers may not add to totals due to rounding.

SOURCE: Hodgson, T. A., and Kopstein, A. N.: Health care expenditures for major diseases in 1980. *Health Care Financing Review*. HCFA Pub. No. 03173. Office of Research and Demonstrations. Health Care Financing Administration. Washington. U.S. Government Printing Office, June 1984.

###### Selected economic variables used in estimating indirect costs, by age and sex: 1980

  Age                Percent of population with earnings   Mean annual earnings[^1^](#tfn17-hcfr-7-1-61){ref-type="table-fn"}   Mean annual value of housekeeping services[^2^](#tfn18-hcfr-7-1-61){ref-type="table-fn"}                                   
  ------------------ ------------------------------------- -------------------------------------------------------------------- ------------------------------------------------------------------------------------------ ---------- ---------- --------- ---------
  15-19 years        62.9                                  57.4                                                                 \$3,456                                                                                    \$ 2,753   \$ 8,274   \$1,895   \$5,592
  20-24 years        90.6                                  80.9                                                                 9,977                                                                                      6,947      10,402     2,044     6,352
  25-29 years        94.5                                  74.0                                                                 16,681                                                                                     10,140     12,595     2,402     7,996
  30-34 years        96.3                                  71.0                                                                 21,076                                                                                     10,497     12,479     2,532     8,861
  35-39 years        96.1                                  68.7                                                                 24,626                                                                                     10,512     11,952     2,481     8,512
  40-44 years        94.4                                  70.2                                                                 25,077                                                                                     10,600     11,222     2,483     7,972
  45-49 years        93.8                                  68.2                                                                 25,978                                                                                     10,543     10,557     2,328     7,351
  50-54 years        90.4                                  62.0                                                                 25,048                                                                                     10,605     10,035     2,328     7,015
  55-59 years        85.1                                  53.1                                                                 24,501                                                                                     10,461     8,732      2,877     6,812
  60-64 years        67.2                                  39.6                                                                 20,410                                                                                     10,035     7,100      2,339     5,539
  65-69 years        35.2                                  18.4                                                                 11,861                                                                                     5,877      5,430      1,789     4,236
  70-74 years        23.0                                  9.4                                                                  9,904                                                                                      4,968      3,866      1,274     3,016
  75-79 years        15.0                                  5.1                                                                  8,266                                                                                      4,205      2,631      867       2,052
  80-84 years        9.7                                   2.6                                                                  6,893                                                                                      3,554      1,530      504       1,193
  85 years or over   6.2                                   1.7                                                                  5,755                                                                                      3,006      866        285       676

Mean annual earnings for year-round full-time workers, including supplements, consisting mainly of employer\'s contributions to social insurance.

Values are imputed by multiplying hours spent in each kind of domestic task by the wages for corresponding occupations.

SOURCES: U.S. Bureau of the Census, *Current Population Reports*, Series P-60, No. 132, "Money Income in 1980 of Families and Persons in the United States." Tables 50 and 52. U.S. Government Printing Office, Washington, DC. Walker, K. E., and Gauger, W. H., "The Dollar Value of Household Work," New York State College of Human Ecology, Information Bulletin 60, Cornell University, Ithaca, New York, 1971 and revised 1980. Brody, W. H. "The Economic Value of a Housewife." *Research and Statistics Note* 9, DHEW Pub. No. SSA 75-11701. Washington, DC, Social Security Administration, Office of Research and Statistics, August 28, 1975.

###### Estimated total person years lost to productivity and morbidity costs, by sex, age, and diagnosis: 1980

  Diagnosis                                                            Total   Sex     Age     Total   Sex     Age                                         
  -------------------------------------------------------------------- ------- ------- ------- ------- ------- ---------- ---------- ---------- ---------- ---------
  Total                                                                6,218   2,853   3,365   4,359   1,859   \$67,827   \$48,305   \$19,522   \$64,168   \$3,659
  Infectious and parasitic diseases                                    293     147     146     266     27      4,107      2,845      1,262      3,963      144
  Neoplasms                                                            426     216     210     355     71      5,778      4,138      1,640      5,552      226
  Endocrine, nutritional, metabolic diseases, and immunity disorders   238     101     137     131     107     2,237      1,673      564        2,096      141
  Diseases of blood and blood-forming organs                           26      10      16      26      6       281        171        110        265        16
  Mental disorders                                                     1,023   514     509     690     333     8,917      7,024      1,893      8,622      295
  Diseases of the nervous system and sense organs                      217     107     110     163     54      2,616      1,905      711        2,467      149
  Diseases of the circulatory system                                   1,388   601     787     569     819     11,448     9,185      2,263      10,258     1,190
  Diseases of the respiratory system                                   807     353     454     704     103     10,146     6,403      3,743      9,793      353
  Diseases of the digestive system                                     266     116     150     227     39      3,441      2,237      1,204      3,270      171
  Diseases of the genitourinary system                                 154     42      112     138     16      1,762      779        983        1,666      96
  Diseases of the skin and subcutaneous tissue                         40      22      18      31      9       539        419        120        502        37
  Diseases of the musculoskeletal system and connective tissue         555     261     294     406     149     6,938      5,114      1,824      6,496      442
  Symptoms, signs, and ill-defined conditions                          153     62      91      114     39      1,847      1,125      722        1,612      235
  injury and poisoning                                                 578     301     277     491     87      7,234      5,287      1,947      7,070      164
  Other conditions[^1^](#tfn20-hcfr-7-1-61){ref-type="table-fn"}       54      ---     54      54      ---     536        ---        536        536        ---

Includes complications of pregnancy, childbirth, and puerperium and certain conditions originating during the perinatal period.

###### Present value of lifetime earnings discounted at 4 percent and 6 percent, by age and sex: 1980

  Age                Male        Female                  
  ------------------ ----------- ----------- ----------- -----------
  Under 1 year       \$415,998   \$200,992   \$330,065   \$166,303
  1-4 years          438,242     222,067     347,443     183,597
  5-9 years          479,294     264,604     379,771     218,641
  10-14 years        529,007     321,232     418,954     265,301
  15-19 years        576,855     382,235     448,842     308,166
  20-24 years        604,379     429,152     448,982     325,736
  25-29 years        597,040     446,490     418,703     314,918
  30-34 years        557,084     434,295     372,595     288,221
  35-39 years        492,083     397,573     322,318     256,285
  40-44 years        412,732     344,695     270,522     221,311
  45-49 years        325,967     281,249     216,805     182,338
  50-54 years        235,464     209,546     163,014     140,696
  55-59 years        145,110     132,720     111,643     98,510
  60-64 years        67,446      62,538      67,282      60,224
  65-69 years        25,887      23,810      37,104      33,453
  70-74 years        12,666      11,750      20,557      18,772
  75-79 years        6,108       5,719       10,952      10,159
  80-84 years        3,002       2,847       4,340       4,115
  85 years or over   914         892         1,197       1,169

###### Number of deaths, estimated total person years lost, and discounted productivity losses, by sex and diagnosis: 1980

  Diagnosis                                                            Total       Male        Female    Total    Male     Female   Productivity losses discounted at 4 percent   Productivity losses discounted at 6 percent                                     
  -------------------------------------------------------------------- ----------- ----------- --------- -------- -------- -------- --------------------------------------------- --------------------------------------------- ---------- ----------- ---------- ----------
  Total                                                                1,989,841   1,075,078   914,763   35,144   19,359   15,785   \$175,912                                     \$123,678                                     \$52,234   \$136,948   \$96,232   \$40,716
  Infectious and parasitic diseases                                    17,288      9,028       8,260     359      181      178      1,859                                         1,153                                         706        1,386       860        526
  Neoplasms                                                            422,702     228,827     193,875   7,239    3,508    3,731    31,711                                        18,354                                        13,357     26,994      15.713     11,281
  Endocrine, nutritional, metabolic diseases, and immunity disorders   46,360      19,286      27,074    772      312      460      3,274                                         1,808                                         1,466      2,645       1,456      1,189
  Diseases of blood and blood-forming organs                           6,376       3,009       3,367     121      55       66       614                                           354                                           260        464         265        199
  Mental disorders                                                     14,026      8,104       5,922     275      175      100      1,944                                         1,541                                         403        1,571       1,249      322
  Diseases of the nervous system and sense organs                      21,744      11,622      10,122    553      290      263      3,243                                         2,103                                         1,140      2,339       1,510      829
  Diseases of the circulatory system                                   993,348     506,154     487,194   12,515   6,524    5,991    41,072                                        28,788                                        12,284     35,722      25,110     10,612
  Diseases of the respiratory system                                   128,828     77,191      51,637    1,788    1,009    779      6,313                                         4,130                                         2,183      5,065       3,334      1,731
  Diseases of the digestive system                                     75,202      41,101      34,101    1,416    772      644      8,022                                         5,573                                         2,449      6,694       4,675      2,019
  Diseases of the genitourinary system                                 29,082      14,562      14,520    385      178      207      1,339                                         774                                           565        1,096       633        463
  Diseases of the skin and subcutaneous tissue                         2,855       1,071       1,784     37       13       24       121                                           60                                            61         99          49         50
  Diseases of the musculoskeletal system and connective tissue         5,533       1,695       3,838     109      28       81       526                                           174                                           352        427         143        284
  Congential anomalies                                                 13,938      7,496       6,442     892      458      434      4,974                                         3,003                                         1,971      2,712       1,625      1,087
  Symptoms, signs, and ill-defined conditions                          28,808      16,465      12,343    891      506      385      5,048                                         3,431                                         1,617      3,297       2,259      1,038
  Injury and poisoning                                                 160,551     116,416     44,135    6,100    4,437    1,663    57,041                                        47,001                                        10,040     42,077      34,725     7,352
  Other conditions[^1^](#tfn21-hcfr-7-1-61){ref-type="table-fn"}       23,200      13,051      10,149    1,692    913      779      8,811                                         5,431                                         3,380      4,360       2,626      1,734

Includes complications of pregnancy, childbirth, and puerperium and certain conditions originating during the perinatal period.

###### Number of deaths, estimated person years lost, and discounted productivity losses, by age and diagnosis: 1980

  Diagnosis                                                            Total       Under 65 years   65 years or over   Total    Under 65 years   65 years or over   Productivity losses discounted at 4 percent   Productivity losses discounted at 6 percent                                     
  -------------------------------------------------------------------- ----------- ---------------- ------------------ -------- ---------------- ------------------ --------------------------------------------- --------------------------------------------- ---------- ---------- ----------- ----------
  Total                                                                1,989,841   647,425          1,341,848          35,144   21,814           13,330             \$175,912                                     \$161,813                                     \$14,099   S136,948   \$123,964   \$12,984
  Infectious and parasitic diseases                                    17,288      6,626            10,656             359      252              107                1,859                                         1,744                                         115        1,386      1,280       106
  Neoplasms                                                            422,702     160,488          262,186            7,239    4,313            2,926              31,711                                        28,061                                        3,650      26,994     23,644      3,350
  Endocrine, nutritional, metabolic diseases, and immunity disorders   46,360      13,703           32,651             772      428              344                3,274                                         2,887                                         387        2,645      2,290       355
  Diseases of blood and blood-forming organs                           6,376       2,075            4,301              121      79               42                 614                                           570                                           44         464        423         41
  Mental disorders                                                     14,026      6,253            7,765              275      206              69                 1,944                                         1,880                                         64         1,571      1,512       59
  Diseases of the nervous system and sense organs                      21,744      10,297           11,445             553      430              123                3,243                                         3,098                                         145        2,339      2,206       133
  Diseases of the circulatory system                                   993,348     198,328          794,844            12,515   4,938            7,577              41,072                                        33,640                                        7,432      35,722     28,866      6,856
  Diseases of the respiratory system                                   128,828     27,115           101,690            1,788    823              965                6,313                                         5,343                                         970        5,065      4,169       896
  Diseases of the digestive system                                     75,202      33,728           41,451             1,416    981              435                8,022                                         7,522                                         500        6,694      6,235       459
  Diseases of the genitourinary system                                 29,082      5,472            23,606             385      167              218                1,339                                         1,134                                         205        1,096      907         189
  Diseases of the skin and subcutaneous tissue                         2,855       500              2,355              37       15               22                 121                                           101                                           20         99         81          18
  Diseases of the musculoskeletal system and connective tissue         5,533       2,163            3,370              109      72               37                 526                                           480                                           46         427        385         42
  Congential anomalies                                                 13,938      13,099           836                892      882              10                 4,974                                         4,961                                         13         2,712      2,700       12
  Symptoms, signs, and ill-defined conditions                          28,808      15,314           13,430             891      758              133                5,048                                         4,906                                         142        3,297      3,166       131
  Injury and poisoning                                                 160,551     129,070          31,260             6,100    5,778            322                57,041                                        56,675                                        366        42,077     41,740      337
  Other conditions[^1^](#tfn22-hcfr-7-1-61){ref-type="table-fn"}       23,200      23,194           2                  1,692    1,692            0                  8,811                                         8,811                                         0          4,360      4,360       0

Includes complications of pregnancy, childbirth, and puerperium and certain conditions originating during the perinatal period.

Includes 568 deaths for which age is not available.

###### Comparison of estimated amounts of total economic costs, by diagnosis: Selected years 1963-80

  Diagnosis                                                            1963       1972        1980        1963    1972    1980
  -------------------------------------------------------------------- ---------- ----------- ----------- ------- ------- -------
  Total                                                                \$93,500   \$188,789   \$415,918   100.0   100.0   100.0
  Infectious and parasitic diseases                                    2,135      3,443       9,793       2.3     1.8     2.4
  Neoplasms                                                            10,590     17,367      45,821      11.3    9.2     11.0
  Endocrine, nutritional, metabolic diseases, and immunity disorders   2,623      5,930       12,211      2.8     3.1     2.9
  Diseases of blood and blood-forming organs                           373        921         1,900       0.4     0.5     0.5
  Mental disorders                                                     7,277      13,917      30,312      7.8     7.4     7.3
  Diseases of the nervous system and sense organs                      6,795      10,951      22,087      7.3     5.8     5.3
  Diseases of the circulatory system                                   20,948     40,060      79,658      22.4    21.2    19.2
  Diseases of the respiratory system                                   7,413      16,454      31,872      7.9     8.7     7.7
  Diseases of digestive system                                         7,837      17,487      41,109      8.4     9.3     9.9
  Diseases of the genitourinary system                                 2,560      6,456       15,171      2.7     3.4     3.6
  Diseases of the skin and subcutaneous tissue                         450        2,052       6,578       0.5     1.1     1.6
  Diseases of the musculoskeletal system and connective tissue         2,783      8,948       20,489      3.0     4.7     4.9
  Congenital anomalies                                                 1,243      1,903       4,057       1.3     1.0     1.0
  Injury and poisoning                                                 11,811     26,678      67,995      12.6    14.1    16.3
  Other[^1^](#tfn24-hcfr-7-1-61){ref-type="table-fn"}                  8,663      16,226      26,866      9.3     8.6     6.5

Includes complications of pregnancy, childbirth, and puerperium; certain conditions originating during the perinatal period; and symptoms, signs, and ill-defined conditions.

Present value of lifetime earnings discounted at 6 percent before adjusting for an annual change in productivity of 2 percent.

NOTE: Numbers and percents may not add due to rounding.

###### Comparison of estimated amounts, percent distributions, and percent increases of total economic costs, by type of cost: Selected years 1963-80

  Type of cost   1963                                                   1972                                                   1980
  -------------- ------------------------------------------------------ ------------------------------------------------------ -----------
                 Amount in millions                                                                                            
  Total          \$93,500                                               \$188,789                                              \$415,918
   Direct        22,530                                                 75,231                                                 211,143
   Indirect      70,970                                                 113,558                                                204,775
    Morbidity    21,042                                                 142,323                                                67,827
    Mortality    [^1^](#tfn27-hcfr-7-1-61){ref-type="table-fn"}49,928   [^1^](#tfn27-hcfr-7-1-61){ref-type="table-fn"}71,235   136,948
                 Percent distribution                                                                                          
  Total          100.0                                                  100.0                                                  100.0
   Direct        24.1                                                   39.8                                                   50.8
   Indirect      75.9                                                   60.2                                                   49.2
    Morbidity    22.5                                                   22.4                                                   16.3
    Mortality    53.4                                                   37.7                                                   32.9
                 Percent increase                                                                                              
  Total          ---                                                    101.9                                                  120.3
   Direct        ---                                                    233.9                                                  180.7
   Indirect      ---                                                    60.0                                                   80.3
    Morbidity    ---                                                    101.1                                                  60.3
    Mortality    ---                                                    42.7                                                   92.2

Present value of lifetime earnings discounted at 6 percent before adjusting for an annual change in productivity of 2 percent.

SOURCES: 1963---Rice, D. P.: Estimating the cost of illness. *Health Economics Series, No. 6*, Publication No. 9476. Washington, DC: U.S. Public Health Services, 1966. 1972---Cooper, B. S., and Rice, D. P.: The economic cost of illness revisited. *Social Security Bulletin*, 39:21-36, 1976.
